Host inactivation of bacterial lipopolysaccharide prevents prolonged tolerance following gram-negative bacterial infection.
about
Polymorphisms in RYBP and AOAH genes are associated with chronic rhinosinusitis in a Chinese population: a replication studyPersistently active microbial molecules prolong innate immune tolerance in vivoMurine responses to endotoxin: another dirty little secret?Chapter 2: Kill the bacteria...and also their messengers?Acyloxyacyl hydrolase promotes the resolution of lipopolysaccharide-induced acute lung injuryHepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexesABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance.Prolonged hepatomegaly in mice that cannot inactivate bacterial endotoxinIntestinal alkaline phosphatase deficiency leads to lipopolysaccharide desensitization and faster weight gainA high-throughput, multiplexed assay for superfamily-wide profiling of enzyme activity.The transport and inactivation kinetics of bacterial lipopolysaccharide influence its immunological potency in vivo.The metabolic serine hydrolases and their functions in mammalian physiology and disease.Decreased Risk of Ventilator-Associated Pneumonia in Sepsis Due to Intra-Abdominal Infection.CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin toleranceTransient lipopolysaccharide-induced resistance to aerosolized Bacillus anthracis in New Zealand white rabbits.Chronic Rhinosinusitis without Nasal Polyps.Overproduction of acyloxyacyl hydrolase by macrophages and dendritic cells prevents prolonged reactions to bacterial lipopolysaccharide in vivo.Altered inactivation of commensal LPS due to acyloxyacyl hydrolase deficiency in colonic dendritic cells impairs mucosal Th17 immunityA role for intestinal alkaline phosphatase in the maintenance of local gut immunityAssessment of Pasteurella multocida A Lipopolysaccharide, as an Adhesin in an In Vitro Model of Rabbit Respiratory Epithelium.Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.Gut-liver axis and sensing microbes.Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis.Gut-liver axis: role of inflammasomes.Novel insights in preventing Gram-negative bacterial infection in cirrhotic patients: review on the effects of GM-CSF in maintaining homeostasis of the immune system.The Characteristics and Function of Bacterial Lipopolysaccharides and Their Endotoxic Potential in Humans.Chasing a ghost?--Issues with the determination of circulating levels of endotoxin in human blood.LPS stimulates IgM production in vivo without help from non-B cells.CETP Lowers TLR4 Expression Which Attenuates the Inflammatory Response Induced by LPS and Polymicrobial Sepsis.Inhibition of antibody production in vivo by pre-stimulation of Toll-like receptor 4 before antigen priming is caused by defective B-cell priming and not impairment in antigen presentation.Microbiome Influences Prenatal and Adult Microglia in a Sex-Specific Manner.Acyloxyacyl hydrolase modulates pelvic pain severity.Crystal structure of the mammalian lipopolysaccharide detoxifier.
P2860
Q21134519-EA2FB808-DC77-422B-96CC-049418E89A8AQ28397918-0FC17117-E574-49B3-BA41-7AB31F282D72Q33557035-46A6ED5C-9AB8-4254-A211-F3DB5683E927Q33616742-8DBEE43A-6F53-48B0-A9FE-3B41543A7CA3Q33848554-B69200BE-7E56-4A01-8D00-B7BBA89320C4Q33997607-7F80E5FA-F4AA-43C8-A91C-3315E44BD461Q34053118-5AA70EFF-39CE-40B1-90B9-1483A9AF69A1Q34192733-3A402A48-FCEC-48AC-9365-CA23DA52DEE5Q34889772-669C441D-5D30-44BE-9AA0-97EE34F1FC13Q35201777-9AEF2407-E70A-4A92-9E08-0826AB612719Q35204664-B8A06C7F-AB8F-4B64-82A6-5F8C87E774B1Q35333042-CE39FAAE-3163-4DA1-8F65-DA33C4669910Q35764508-C0B24DC7-18EA-4A07-B359-753E4C5F2FC8Q35845957-6C896449-D9DF-48C6-8937-E4E873DE332EQ36949041-8F76BE67-D24A-4C49-93DC-A6467644CFA0Q37080779-9C65EB75-83CA-4D83-911A-D3A7FDF26505Q37441225-EC83C622-D709-449E-A9BC-1636EBDBBEBFQ37475149-A55A43A4-5406-482B-8AD6-00957E4B8A19Q37596740-D36D900C-E8DF-42E2-8AB5-0C9746805B56Q37637325-523A7054-C64F-482D-9BAF-C5A243DA984AQ37655890-903AF866-F4D4-4336-8F22-DA9EA25B6DB2Q37869765-78A84846-9BFE-4EE0-887D-3B6388DAA17EQ38113080-F0FC2F78-6F04-470E-8A29-3C3CD47506D4Q38371533-4F1D71BB-382C-4B3F-B255-56AD5E83B659Q38383499-C88C9521-372F-485C-BB0D-7EE45B1C9043Q38647533-A9715B80-5DF1-4143-8630-CC183CB2F5BEQ38687215-C6C7E381-7ADB-42E7-AB11-7D46D43ECE71Q40670843-24AAE77F-DF08-403F-A1E9-9B07F1A7948CQ42103732-910305D5-DE1C-45CD-AF42-F6F537E2CAFFQ43710319-C5630905-FB68-4979-8ED4-25578C1F792BQ47560330-16796461-FE9F-4202-9472-A50A322CAA60Q47586079-C74A1E14-882F-4237-B57D-E2FFAF257D98Q48223653-24D15313-1E9E-456F-9DB9-41F75AD62774
P2860
Host inactivation of bacterial lipopolysaccharide prevents prolonged tolerance following gram-negative bacterial infection.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Host inactivation of bacterial ...... -negative bacterial infection.
@ast
Host inactivation of bacterial ...... -negative bacterial infection.
@en
Host inactivation of bacterial ...... -negative bacterial infection.
@nl
type
label
Host inactivation of bacterial ...... -negative bacterial infection.
@ast
Host inactivation of bacterial ...... -negative bacterial infection.
@en
Host inactivation of bacterial ...... -negative bacterial infection.
@nl
prefLabel
Host inactivation of bacterial ...... -negative bacterial infection.
@ast
Host inactivation of bacterial ...... -negative bacterial infection.
@en
Host inactivation of bacterial ...... -negative bacterial infection.
@nl
P2093
P2860
P1433
P1476
Host inactivation of bacterial ...... -negative bacterial infection.
@en
P2093
Alan W Varley
John Hardwick
Mingfang Lu
Robert S Munford
Shoichiro Ohta
P2860
P304
P356
10.1016/J.CHOM.2008.06.009
P577
2008-09-01T00:00:00Z